Liquidia CORP Form 4 insider transactions
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Medical Officer, Rajeev Saggar, reported the vesting of performance stock units and a subsequent sale of shares to cover tax obligations, as detailed in a recent SEC Form 4 filing.
NASDAQ
LQDA
Liquidia CORPForm 4: Liquidia CEO Roger Jeffs Reports Vesting of Performance Stock Units and Tax-Related Stock Sale
Liquidia Corp's CEO, Roger Jeffs, reported the vesting of 69,169 performance stock units and the subsequent sale of 30,610 common shares at $16.97 to cover tax obligations, as part of a pre-arranged trading plan.
NASDAQ
LQDA
Liquidia CORPForm 4: Liquidia CFO and COO Michael Kaseta Reports Routine Stock Vesting and Tax-Related Share Sale
Liquidia Corp's CFO and COO, Michael Kaseta, reported the vesting of performance stock units and a subsequent sale of shares to cover tax obligations, executed under a pre-arranged trading plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, reported the vesting of performance stock units and a subsequent sale of shares to cover tax obligations, executed under a pre-arranged 10b5-1 plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's General Counsel, Russell Schundler, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations, as detailed in a recent SEC Form 4 filing.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Commercial Officer, Scott Moomaw, reported the vesting of 1,875 restricted stock units and the subsequent sale of 581 shares to cover tax obligations.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO and COO, Michael Kaseta, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations, executed under a pre-arranged 10b5-1 plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, reported the acquisition of common stock through RSU vesting and a subsequent sale of shares to cover tax obligations, all executed under a pre-arranged 10b5-1 trading plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, sold 455 shares of common stock on April 28, 2025, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, sold 2,450 shares of common stock on April 21, 2025, to cover taxes associated with the vesting of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's General Counsel, Russell Schundler, sold shares of common stock to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp CEO Roger Jeffs sold 14,130 shares of common stock on April 14, 2025, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPScott Moomaw, Chief Commercial Officer of Liquidia Corp, sold 3,406 shares of common stock on April 15, 2025, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, sold 8,283 shares of common stock on April 14, 2025, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling shares to cover taxes associated with the vesting of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, reports the vesting and sale of common stock to cover taxes, alongside ongoing holdings of restricted stock units.
NASDAQ
LQDA
Liquidia CORPChief Business Officer Jason Adair reports stock transactions, including the vesting and sale of restricted stock units, under a pre-arranged trading plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's General Counsel, Russell Schundler, reports the vesting and sale of restricted stock units (RSUs) and a sale of common stock to cover taxes.
NASDAQ
LQDA
Liquidia CORPChief Commercial Officer Scott Moomaw reports stock transactions including RSU vesting and sales to cover taxes.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, reports the vesting and sale of restricted stock units (RSUs) and stock sales under a 10b5-1 plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, sold 445 shares of common stock to cover taxes associated with the settlement of restricted stock units.
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling shares to cover taxes associated with the vesting of restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's General Counsel, Russell Schundler, reports the acquisition of stock units and the sale of shares to cover taxes.
NASDAQ
LQDA
Liquidia CORPRajeev Saggar, Chief Medical Officer of Liquidia Corp, reports acquisition of performance stock units and sale of common stock to cover taxes.
NASDAQ
LQDA
Liquidia CORPChief Commercial Officer Scott Moomaw reports acquisition of performance stock units and sale of common stock to cover taxes.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, reports acquisition and disposal of company stock and performance stock units.
NASDAQ
LQDA
Liquidia CORPChief Business Officer Jason Adair reports acquisition and disposal of Liquidia Corp stock, including vesting of restricted stock units and performance stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CEO, Roger Jeffs, reports acquisition and disposal of common stock, along with a grant of performance stock units (PSUs).
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Commercial Officer, Scott Moomaw, reports the vesting of restricted stock units and subsequent sale of shares to cover taxes.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO, Michael Kaseta, reports the vesting of restricted stock units and subsequent sale of shares to cover taxes.